| Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ... Immunity 54 (8), 1853-1868. e7, 2021 | 268 | 2021 |
| A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction M Ejemel, Q Li, S Hou, ZA Schiller, JA Tree, A Wallace, A Amcheslavsky, ... Nature Communications 11 (1), 4198, 2020 | 165 | 2020 |
| Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes EP Cai, Y Ishikawa, W Zhang, NC Leite, J Li, S Hou, B Kiaf, ... Nature metabolism 2 (9), 934-945, 2020 | 81 | 2020 |
| Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions TV Silvas, S Hou, W Myint, E Nalivaika, M Somasundaran, BA Kelch, ... Scientific reports 8 (1), 7511, 2018 | 65 | 2018 |
| Drug design strategies to avoid resistance in direct-acting antivirals and beyond AN Matthew, F Leidner, GJ Lockbaum, M Henes, J Zephyr, S Hou, ... Chemical reviews 121 (6), 3238-3270, 2021 | 61 | 2021 |
| Mutations in influenza A virus neuraminidase and hemagglutinin confer resistance against a broadly neutralizing hemagglutinin stem antibody KL Prachanronarong, AS Canale, P Liu, M Somasundaran, S Hou, ... Journal of virology 93 (2), 10.1128/jvi. 01639-18, 2019 | 57 | 2019 |
| Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ... BioRxiv, 2021 | 42 | 2021 |
| Structural analysis of the active site and DNA binding of human cytidine deaminase APOBEC3B S Hou, TV Silvas, F Leidner, EA Nalivaika, H Matsuo, N Kurt Yilmaz, ... Journal of chemical theory and computation 15 (1), 637-647, 2018 | 27 | 2018 |
| Structural determination of the broadly reactive anti-IGHV1-69 anti-idiotypic antibody G6 and its idiotope Y Avnir, KL Prachanronarong, Z Zhang, S Hou, EC Peterson, J Sui, ... Cell reports 21 (11), 3243-3255, 2017 | 24 | 2017 |
| Interactions of APOBEC3s with DNA and RNA A Maiti, S Hou, CA Schiffer, H Matsuo Current opinion in structural biology 67, 195-204, 2021 | 22 | 2021 |
| Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s S Hou, JM Lee, W Myint, H Matsuo, NK Yilmaz, CA Schiffer Journal of Biological Chemistry 297 (2), 2021 | 21 | 2021 |
| IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity M Ejemel, Q Li, S Hou, ZA Schiller, AL Wallace, A Amcheslavsky, ... BioRxiv, 2020.05. 15.096719, 2020 | 19 | 2020 |
| Unique structural solution from a VH3-30 antibody targeting the hemagglutinin stem of influenza A viruses WD Harshbarger, D Deming, GJ Lockbaum, N Attatippaholkun, ... Nature Communications 12 (1), 559, 2021 | 17 | 2021 |
| Crystal structure of a soluble APOBEC3G variant suggests ssDNA to bind in a channel that extends between the two domains A Maiti, W Myint, KA Delviks-Frankenberry, S Hou, T Kanai, ... Journal of molecular biology 432 (23), 6042-6060, 2020 | 13 | 2020 |
| Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA WC Solomon, W Myint, S Hou, T Kanai, R Tripathi, N Kurt Yilmaz, ... Nucleic Acids Research 47 (14), 7676-7689, 2019 | 12 | 2019 |
| Molecular and structural mechanism of pan-genotypic HCV NS3/4A protease inhibition by glecaprevir J Timm, K Kosovrasti, M Henes, F Leidner, S Hou, A Ali, N Kurt Yilmaz, ... ACS chemical biology 15 (2), 342-352, 2019 | 11 | 2019 |
| Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies [preprint] F Muecksch, S Hou, CA Schiffer, M Nussenzweig, PJ Bjorkman, ... | | 2021 |
| IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity [preprint] E Monir, Q Li, S Hou, Z Schiller, A Wallace, A Amcheslavsky, NK Yilmaz, ... | | 2020 |
| Structural Mechanism of Substrate Specificity in Human Cytidine Deaminase Family APOBEC3s S Hou, EA Nalivaika, W Myint, H Matsuo, NK Yilmaz, CA Schiffer The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Molecular and structural mechanism of pan-genotypic HCV NS3/4A protease inhibition by glecaprevir [preprint] J Timm, K Kosovrasti, M Henes, F Leidner, S Hou, A Ali, NK Yilmaz, ... | | 2019 |
